NorthRock Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
NorthRock Partners's ELV Position: Q3 2026 in Review
NorthRock Partners reduced its Elevance Health (ELV) stake by 4.3% in Q3 2026, selling an estimated $15.6K and leaving 878 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #513.
NorthRock Partners first reported a position in ELV in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.1M in Q2 2024. 1,616 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- NorthRock Partners held 878 shares of Elevance Health worth $342K as of Q3 2026.
- NorthRock Partners sold 39 Elevance Health shares in Q3 2026, an estimated $15.6K.
- Elevance Health made up ﹤0.01% of NorthRock Partners's portfolio in Q3 2026, its #513 holding.
- NorthRock Partners first reported a position in Elevance Health in Q3 2021 and has held it in 21 quarters since.
- NorthRock Partners's Elevance Health position peaked at $1.1M in Q2 2024.
- 1,616 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on NorthRock Partners's 13F filing for Q3 2026, filed 13 Nov 2026.